Skip to content

Affinity Asset Advisors, LLC

Follow

13F filer, CIK 1773195, NEW YORK, NY

Affinity Asset Advisors, LLC reported $2,457,611,956 across 121 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 41.65% of the portfolio.

Accepted , ingested 13F-HR 0001011438-26-000687

Period
2026-09-30
Reported value
$2.46B
Holdings
121
Top 10 weight
41.65%
New
33
Sold out
25

Part of the filer group Affinity Asset Advisors, LLC

  • Michael Cho
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
VOGXnew+915,000$20.9M
ARWRadded+275,000$18M
ALKSadded+440,000$17.8M
ARVNnew+2,050,000$15.9M
CLDXadded+460,499$14.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
APGEexited-987,000-$131M
ANABreduced-759,645-$38.2M
NUVLexited-275,000-$34M
FBRXexited-1,145,391-$24.3M
ROIVreduced-550,000-$20.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001011438-26-000687, largest first. % of portfolio is the value over $1,762,875,477, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 150,000 shares; 2025Q2: 400,000 shares; 2025Q3: 800,000 shares; 2025Q4: 1,700,000 shares; 2026Q1: 2,800,000 shares; 2026Q2: 3,750,000 shares; 2026Q3: 3,200,000 shares 3,200,000$117M6.64%-550,000Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 824,328 shares; 2025Q1: 481,678 shares; 2025Q2: 606,678 shares; 2025Q3: 1,419,299 shares; 2025Q4: 1,432,591 shares; 2026Q1: 1,279,134 shares; 2026Q2: 1,279,134 shares; 2026Q3: 1,279,134 shares 1,279,134$114M6.46%0Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,499,431 shares; 2025Q1: 3,341,519 shares; 2025Q2: 4,085,787 shares; 2025Q3: 4,285,787 shares; 2025Q4: 3,900,000 shares; 2026Q1: 5,350,000 shares; 2026Q2: 5,250,000 shares; 2026Q3: 5,590,600 shares 5,590,600$82M4.65%+340,600Timeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,032,012 shares; 2026Q3: 2,080,000 shares 2,080,000$73.7M4.18%+47,988Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,161,237 shares; 2025Q1: 1,328,175 shares; 2025Q2: 1,100,000 shares; 2025Q3: 1,400,000 shares; 2025Q4: 1,250,000 shares; 2026Q1: 1,675,000 shares; 2026Q2: 1,595,000 shares; 2026Q3: 1,900,374 shares 1,900,374$70.7M4.01%+305,374Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,000 shares; 2025Q1: 140,000 shares; 2025Q2: 475,000 shares; 2025Q3: 450,000 shares; 2025Q4: 450,000 shares; 2026Q1: 480,000 shares; 2026Q2: 650,000 shares; 2026Q3: 564,251 shares 564,251$64.4M3.65%-85,749Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,100,000 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,000,000 shares; 2025Q3: 1,250,000 shares; 2025Q4: 1,000,000 shares; 2026Q1: 1,350,000 shares; 2026Q2: 1,125,000 shares; 2026Q3: 1,565,000 shares 1,565,000$63.4M3.6%+440,000Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 368,698 shares; 2025Q1: 545,362 shares; 2025Q2: 603,479 shares; 2025Q3: 959,180 shares; 2025Q4: 802,342 shares; 2026Q1: 499,673 shares; 2026Q2: 590,000 shares; 2026Q3: 600,000 shares 600,000$50M2.83%+10,000Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 550,765 shares; 2025Q1: 657,154 shares; 2025Q2: 607,872 shares; 2025Q3: 1,006,217 shares; 2025Q4: 1,051,054 shares; 2026Q1: 1,340,840 shares; 2026Q2: 2,900,000 shares; 2026Q3: 3,244,861 shares 3,244,861$49.7M2.82%+344,861Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 350,000 shares; 2025Q4: 800,000 shares; 2026Q1: 700,483 shares; 2026Q2: 550,000 shares; 2026Q3: 750,000 shares 750,000$49.4M2.8%+200,000Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 250,000 shares; 2026Q3: 225,000 shares 225,000$46.2M2.62%-25,000Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 185,000 shares; 2026Q1: 170,000 shares; 2026Q2: 185,000 shares; 2026Q3: 155,000 shares 155,000$45.1M2.56%-30,000Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 65,000 shares; 2026Q2: 165,000 shares; 2026Q3: 242,088 shares 242,088$41.1M2.33%+77,088Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,992 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 350,000 shares; 2026Q1: 500,000 shares; 2026Q2: 700,000 shares; 2026Q3: 1,160,499 shares 1,160,499$37.6M2.13%+460,499Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 200,000 shares; 2025Q2: 100,000 shares; 2025Q3: 360,000 shares; 2025Q4: 505,000 shares; 2026Q1: 405,000 shares; 2026Q2: 330,000 shares; 2026Q3: 330,000 shares 330,000$32.7M1.85%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 262,100 shares; 2025Q4: 115,000 shares; 2026Q1: 350,000 shares; 2026Q2: 400,000 shares; 2026Q3: 350,000 shares 350,000$30.8M1.75%-50,000Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 766,346 shares; 2026Q3: 1,260,000 shares 1,260,000$28M1.59%+493,654Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,000 shares; 2026Q1: 200,000 shares; 2026Q2: 150,000 shares; 2026Q3: 425,000 shares 425,000$27.8M1.58%+275,000Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,250,000 shares; 2025Q2: 2,534,058 shares; 2025Q3: 2,800,000 shares; 2025Q4: 2,150,172 shares; 2026Q1: 2,000,172 shares; 2026Q2: 1,800,172 shares; 2026Q3: 1,800,172 shares 1,800,172$25.8M1.46%0Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 667,516 shares; 2025Q2: 667,516 shares; 2025Q3: 2,650,000 shares; 2025Q4: 7,150,000 shares; 2026Q1: 10,636,318 shares; 2026Q2: 10,144,562 shares; 2026Q3: 10,144,562 shares 10,144,562$25.3M1.43%0Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 350,000 shares; 2025Q4: 1,148,245 shares; 2026Q1: 868,020 shares; 2026Q2: 2,497,864 shares; 2026Q3: 2,527,384 shares 2,527,384$25M1.42%+29,520Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,480,881 shares; 2025Q2: 3,589,355 shares; 2025Q3: 3,870,527 shares; 2025Q4: 3,200,000 shares; 2026Q1: 5,050,211 shares; 2026Q2: 5,807,611 shares; 2026Q3: 7,245,611 shares 7,245,611$24.5M1.39%+1,438,000Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 130,000 shares; 2025Q1: 400,000 shares; 2025Q2: 440,000 shares; 2025Q3: 220,600 shares; 2025Q4: 172,125 shares; 2026Q1: 172,125 shares; 2026Q2: 172,125 shares; 2026Q3: 172,125 shares 172,125$24.3M1.38%0Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 940,083 shares; 2025Q1: 810,669 shares; 2025Q2: 967,620 shares; 2025Q3: 967,620 shares; 2025Q4: 967,620 shares; 2026Q1: 967,620 shares; 2026Q2: 967,620 shares; 2026Q3: 967,620 shares 967,620$22.9M1.3%0Timeline
VOGXVOGENX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 915,000 shares 915,000$20.9M1.18%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 350,000 shares; 2025Q1: 1,100,000 shares; 2025Q2: 900,000 shares; 2025Q3: 750,000 shares; 2025Q4: 730,000 shares; 2026Q1: 750,000 shares; 2026Q2: 750,000 shares; 2026Q3: 750,000 shares 750,000$18.8M1.07%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 257,512 shares; 2026Q2: 200,012 shares; 2026Q3: 850,000 shares 850,000$18.6M1.05%+649,988Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 748,382 shares; 2026Q1: 1,069,519 shares; 2026Q2: 1,172,487 shares; 2026Q3: 1,152,487 shares 1,152,487$18.6M1.05%-20,000Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,000 shares; 2025Q1: 1,070,000 shares; 2025Q2: 970,000 shares; 2025Q3: 500,000 shares; 2025Q4: 300,000 shares; 2026Q1: 300,000 shares; 2026Q2: 300,000 shares; 2026Q3: 300,000 shares 300,000$17.7M1%0Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 500,000 shares; 2026Q2: 850,000 shares; 2026Q3: 643,343 shares 643,343$16.4M0.93%-206,657Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 630,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,050,000 shares 2,050,000$15.9M0.9%newTimeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 1,589,005 shares; 2026Q2: 1,650,000 shares; 2026Q3: 1,716,320 shares 1,716,320$15.6M0.89%+66,320Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 400,000 shares; 2026Q2: 1,050,000 shares; 2026Q3: 850,000 shares 850,000$15.3M0.87%-200,000Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 82,500 shares; 2025Q1: 80,000 shares; 2025Q2: 80,000 shares; 2025Q3: 115,000 shares; 2025Q4: 31,131 shares; 2026Q1: 55,000 shares; 2026Q2: 40,000 shares; 2026Q3: 30,000 shares 30,000$15.1M0.86%-10,000Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 263,817 shares; 2025Q1: 263,817 shares; 2025Q2: 263,817 shares; 2025Q3: 263,817 shares; 2025Q4: 1,932,106 shares; 2026Q1: 781,260 shares; 2026Q2: 875,760 shares; 2026Q3: 875,760 shares 875,760$13.4M0.76%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 410,586 shares; 2025Q1: not reported; 2025Q2: 500,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 2,797,153 shares; 2026Q1: 2,512,153 shares; 2026Q2: 2,512,153 shares; 2026Q3: 2,512,153 shares 2,512,153$13M0.74%0Timeline
COAGHEMAB THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 138,030 shares; 2026Q3: 420,000 shares 420,000$13M0.73%+281,970Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,000 shares; 2025Q1: 1,500,000 shares; 2025Q2: 1,500,000 shares; 2025Q3: 1,300,000 shares; 2025Q4: 1,300,000 shares; 2026Q1: 700,000 shares; 2026Q2: 972,000 shares; 2026Q3: 972,000 shares 972,000$11.1M0.63%0Timeline
IBRXIMMUNITYBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,180,000 shares 1,180,000$11.1M0.63%newTimeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000$11M0.62%newTimeline
CATXPERSPECTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,300,000 shares; 2025Q1: 2,224,196 shares; 2025Q2: 1,050,000 shares; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 3,164,582 shares; 2026Q2: 4,214,582 shares; 2026Q3: 3,988,744 shares 3,988,744$11M0.62%-225,838Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 65,317 shares; 2025Q3: 65,317 shares; 2025Q4: 714,956 shares; 2026Q1: 639,956 shares; 2026Q2: 840,350 shares; 2026Q3: 760,350 shares 760,350$10.7M0.61%-80,000Timeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,600,000 shares 2,600,000$10.2M0.58%newTimeline
CRSPCRISPR THERAPEUTICS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 150,000 shares; 2026Q2: 100,000 shares; 2026Q3: 175,000 shares 175,000$9.68M0.55%+75,000Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 70,000 shares; 2026Q2: 100,000 shares; 2026Q3: 79,400 shares 79,400$9.63M0.55%-20,600Timeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 279,445 shares; 2025Q1: 280,000 shares; 2025Q2: 334,863 shares; 2025Q3: 310,000 shares; 2025Q4: 200,000 shares; 2026Q1: 100,000 shares; 2026Q2: 148,013 shares; 2026Q3: 149,779 shares 149,779$9.61M0.55%+1,766Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 98,999 shares; 2026Q3: 300,000 shares 300,000$8.73M0.5%+201,001Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 263,106 shares 263,106$8.42M0.48%newTimeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,825,000 shares; 2025Q1: 3,284,512 shares; 2025Q2: 3,499,512 shares; 2025Q3: 3,600,000 shares; 2025Q4: 2,454,278 shares; 2026Q1: 2,454,278 shares; 2026Q2: 5,543,936 shares; 2026Q3: 4,970,074 shares 4,970,074$8.25M0.47%-573,862Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 425,000 shares; 2025Q1: 355,143 shares; 2025Q2: 545,000 shares; 2025Q3: 303,330 shares; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000$8.07M0.46%0Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 375,000 shares 375,000$7.98M0.45%newTimeline
RACCRESEARCH ALLIANCE CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 370,000 shares; 2026Q3: 735,538 shares 735,538$7.97M0.45%+365,538Timeline
SLGLSOL-GEL TECHNOLOGIES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,000 shares; 2026Q2: 84,900 shares; 2026Q3: 105,000 shares 105,000$7.8M0.44%+20,100Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares; 2026Q3: 200,000 shares 200,000$7.68M0.44%-200,000Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: 390,000 shares; 2025Q2: 425,000 shares; 2025Q3: 450,000 shares; 2025Q4: 486,684 shares; 2026Q1: 912,397 shares; 2026Q2: 912,397 shares; 2026Q3: 912,397 shares 912,397$7.09M0.4%0Timeline
AKTSAKTIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 350,000 shares 350,000$6.81M0.39%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 400,000 shares; 2025Q3: 400,000 shares; 2025Q4: not reported; 2026Q1: 586,904 shares; 2026Q2: 500,000 shares; 2026Q3: 148,000 shares 148,000$6.78M0.38%-352,000Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 425,000 shares; 2025Q1: 325,000 shares; 2025Q2: 275,000 shares; 2025Q3: 275,000 shares; 2025Q4: 275,000 shares; 2026Q1: 275,000 shares; 2026Q2: 275,000 shares; 2026Q3: 275,000 shares 275,000$6.69M0.38%0Timeline
HLXCHELIX ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,250,000 shares; 2026Q2: 1,250,000 shares; 2026Q3: 625,000 shares 625,000$6.64M0.38%-625,000Timeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 145,000 shares; 2026Q1: 145,000 shares; 2026Q2: 145,000 shares; 2026Q3: 2,062,500 shares 2,062,500$5.98M0.34%+1,917,500Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 706,904 shares; 2026Q2: 706,904 shares; 2026Q3: 531,904 shares 531,904$5.27M0.3%-175,000Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 159,614 shares; 2025Q1: 390,000 shares; 2025Q2: 390,000 shares; 2025Q3: 250,000 shares; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000$5.15M0.29%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000$4.92M0.28%newTimeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,057,200 shares; 2026Q1: 3,107,200 shares; 2026Q2: 4,007,881 shares; 2026Q3: 4,130,427 shares 4,130,427$4.87M0.28%+122,546Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 200,000 shares; 2025Q3: 3,000,000 shares; 2025Q4: 3,300,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 1,750,000 shares; 2026Q3: 1,000,000 shares 1,000,000$4.87M0.28%-750,000Timeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 575,000 shares; 2026Q2: 1,525,000 shares; 2026Q3: 1,525,000 shares 1,525,000$4.83M0.27%0Timeline
IRDOPUS GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 900,000 shares 900,000$4.36M0.25%newTimeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 144,404 shares; 2026Q3: 144,404 shares 144,404$4.29M0.24%0Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,226,310 shares; 2026Q2: 4,100,000 shares; 2026Q3: 2,613,954 shares 2,613,954$4.25M0.24%-1,486,046Timeline
NTLAINTELLIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 350,000 shares 350,000$4.22M0.24%newTimeline
LTGOLATIGO BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000$4.17M0.24%newTimeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,575,000 shares; 2025Q1: 1,700,000 shares; 2025Q2: 2,200,000 shares; 2025Q3: 2,100,000 shares; 2025Q4: 2,351,144 shares; 2026Q1: 1,547,641 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000$4.14M0.23%0Timeline
ARKGARK ETF TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 74,900 shares 74,900$4.06M0.23%newTimeline
DTILPRECISION BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 597,946 shares; 2026Q2: 646,576 shares; 2026Q3: 646,576 shares 646,576$4.05M0.23%0Timeline
AMANAMANAT ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 375,000 shares; 2026Q3: 375,000 shares 375,000$4M0.23%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 850,512 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares; 2025Q4: 200,000 shares; 2026Q1: 1,108,483 shares; 2026Q2: 301,183 shares; 2026Q3: 301,183 shares 301,183$3.75M0.21%0Timeline
RNAQURAINIER ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 364,957 shares 364,957$3.72M0.21%newTimeline
MGNXMACROGENICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 484,308 shares; 2026Q1: 500,000 shares; 2026Q2: 1,216,606 shares; 2026Q3: 953,979 shares 953,979$3.68M0.21%-262,627Timeline
RACDRESEARCH ALLIANCE CORP IVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$3.6M0.2%newTimeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 100,000 shares; 2025Q1: 430,000 shares; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 200,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$3.38M0.19%0Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 444,692 shares; 2026Q1: 940,000 shares; 2026Q2: 826,109 shares; 2026Q3: 66,464 shares 66,464$3.34M0.19%-759,645Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 223,335 shares; 2025Q1: 223,335 shares; 2025Q2: 223,335 shares; 2025Q3: 1,274,351 shares; 2025Q4: 1,813,671 shares; 2026Q1: 2,564,303 shares; 2026Q2: 1,464,303 shares; 2026Q3: 800,000 shares 800,000$3.33M0.19%-664,303Timeline
NAMSWNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 237,935 shares; 2025Q1: 241,957 shares; 2025Q2: 245,000 shares; 2025Q3: 245,000 shares; 2025Q4: 245,000 shares; 2026Q1: 245,000 shares; 2026Q2: 245,000 shares; 2026Q3: 245,000 shares 245,000$3.31M0.19%0Timeline
VRCAVERRICA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 707,338 shares; 2026Q1: 707,338 shares; 2026Q2: 707,338 shares; 2026Q3: 688,654 shares 688,654$3.3M0.19%-18,684Timeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 150,000 shares; 2026Q1: 175,000 shares; 2026Q2: 125,000 shares; 2026Q3: 100,000 shares 100,000$3.03M0.17%-25,000Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 175,000 shares; 2025Q2: not reported; 2025Q3: 165,000 shares; 2025Q4: 250,000 shares; 2026Q1: 150,000 shares; 2026Q2: 75,000 shares; 2026Q3: 50,000 shares 50,000$2.93M0.17%-25,000Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,750,000 shares 1,750,000$2.92M0.17%newTimeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 400,000 shares 400,000$2.89M0.16%newTimeline
OACCUOAKTREE ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 250,000 shares; 2025Q1: 250,000 shares; 2025Q2: 250,000 shares; 2025Q3: 250,000 shares; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000$2.72M0.15%0Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 934,412 shares 934,412$2.72M0.15%newTimeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,070,651 shares; 2026Q3: 4,500,000 shares 4,500,000$2.68M0.15%+3,429,349Timeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000$2.5M0.14%newTimeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 164,748 shares; 2026Q2: 153,847 shares; 2026Q3: 153,847 shares 153,847$2.46M0.14%0Timeline
EIKNEIKON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 98,001 shares; 2026Q3: 298,001 shares 298,001$2.4M0.14%+200,000Timeline
JTTTJATT III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 211,993 shares 211,993$2.34M0.13%newTimeline
JATTJATT II ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000$2.25M0.13%0Timeline
SPROSPERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,300,000 shares 1,300,000$1.57M0.09%newTimeline
GENBGENERATE BIOMEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 350,000 shares; 2026Q2: 400,000 shares; 2026Q3: 100,000 shares 100,000$1.5M0.09%-300,000Timeline
NXTCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 191,882 shares; 2025Q4: 247,294 shares; 2026Q1: 241,826 shares; 2026Q2: 41,960 shares; 2026Q3: 291,960 shares 291,960$1.46M0.08%+250,000Timeline
LENZLENZ THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 300,000 shares 300,000$1.15M0.07%+200,000Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,850,000 shares 1,850,000$1.07M0.06%newTimeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$716K0.04%newTimeline
SLSSELLAS LIFE SCIENCES GROUP IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$616K0.03%newTimeline
ENTAENANTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 29,300 shares 29,300$386K0.02%newTimeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 27,777 shares; 2025Q1: 27,777 shares; 2025Q2: 27,777 shares; 2025Q3: 27,777 shares; 2025Q4: 27,777 shares; 2026Q1: 27,777 shares; 2026Q2: 27,777 shares; 2026Q3: 27,777 shares 27,777$230K0.01%0Timeline
ADGMADAGIO MED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 213,235 shares; 2025Q1: 213,235 shares; 2025Q2: 80,000 shares; 2025Q3: 80,000 shares; 2025Q4: 80,000 shares; 2026Q1: 80,000 shares; 2026Q2: 80,000 shares; 2026Q3: 80,000 shares 80,000$12.2K<0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
IWMISHARES TR SHSput1,000,000$278Mnew
XBISPDR SERIES TRUST S&P BIOTECHput600,000$94.6Mnew
MRNAMODERNA INC COMput325,000$62.6M-175,000
ARKGARK ETF TR GENOMIC REV ETFput1,000,000$54.2Mnew
ARKGARK ETF TR GENOMIC REV ETFcall950,000$51.5M+200,000
MRNAMODERNA INC COMcall250,000$48.1M-225,000
IBRXIMMUNITYBIO INC COMput4,308,700$40.7Mnew
SMMTSUMMIT THERAPEUTICS INC COMput1,700,000$28.7Mnew
ALKSALKERMES PLC SHScall615,400$24.9M+365,400
RAREULTRAGENYX PHARMACEUTICAL IN COMput353,100$5.31Mnew
RAREULTRAGENYX PHARMACEUTICAL IN COMcall250,000$3.76Mnew
IBRXIMMUNITYBIO INC COMcall250,000$2.36Mnew

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
OMEROS CORPOMEROS CORP NOTE 9.500% 6/1principal6,525,000$21.2M0
COGENT BIOSCIENCES INCCOGENT BIOSCIENCES INC NOTE 1.625%11/1principal11,000,000$12.1M0
CELCUITY INCCELCUITY INC Convertibleprincipal8,000,000$7.75M+6,000,000

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
APGEAPOGEE THERAPEUTICS INC987,000$131Mshares
NUVLNUVALENT INC275,000$34Mshares
FBRXFORTE BIOSCIENCES INC1,145,391$24.3Mshares
LLYELI LILLY & CO20,000$24Mcall
COGTCOGENT BIOSCIENCES INC450,000$17.4Mshares
OMEROMEROS CORP1,411,300$13.4Mput
TEVATEVA PHARMACEUTICAL INDS LTD374,000$12.7Mshares
DMRADAMORA THERAPEUTICS INC425,000$11.1Mshares
QUREUNIQURE NV200,000$9.21Mcall
QUREUNIQURE NV175,000$8.06Mshares
ASNDASCENDIS PHARMA A/S30,000$8Mshares
EVMNEVOMMUNE INC500,100$6.65Mput
ASMBASSEMBLY BIOSCIENCES INC190,000$5.22Mshares
BHVNBIOHAVEN LTD250,000$3.72Mshares
KPTIKARYOPHARM THERAPEUTICS INC312,500$3.05Mshares
ALECALECTOR INC1,510,000$3.04Mshares
SGPSPYGLASS PHARMA INC131,586$2.93Mshares
CRNXCRINETICS PHARMACEUTICALS IN75,000$2.81Mshares
SPRBSPRUCE BIOSCIENCES INC30,000$1.62Mshares
SMMTSUMMIT THERAPEUTICS INC100,000$1.46Mcall
OKURONKURE THERAPEUTICS INC240,963$1.1Mshares
ENGNENGENE THERAPEUTICS INC600,000$1.04Mshares
BOLDBOUNDLESS BIO INC250,000$625Kshares
OBIOORCHESTRA BIOMED HLDGS INC33,400$144Kshares
RCKTWROCKET PHARMACEUTICALS INC75,000$278shares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001011438-26-000687 base2026-11-13